Vivitrol Manufacturer Tries to Corner the Market on Opioid Medication Treatment

A drug manufacturer is at it again. Manufacturer, Alkermes, the maker of Vivitrol, is cashing in on the opioid epidemic. They are successfully lobbying legislation to pass bills in support of Vivitrol. Vivitrol is an opioid blocker which should prevent addicts from experiencing euphoria if they take heroin or pain killers. It also cuts cravings. These are also the properties of Methadone and Suboxone. Vivitrol is costly at $1000 for a shot that remains in the system for one month. Alkermes made $209 million in 2016 through their lobbying efforts coast to coast. They are alleged to be giving misinformation about Methadone and Suboxone and purposefully lobbying to restrict their use. Listen in to this opiate support group as they talk about this issue.

Discussion Guide:

Are you familiar with Vivitrol? What do you know about it, and have you been treated with it?

Do you believe that Vivitrol should be legislated for use, over Methadone and Suboxone?

What are the pros and cons of each of these medications in terms of cost, administration and adjunct treatment? (Vivitrol, Methadone and Suboxone)

What types of patients would do better on each?

Supplemental Reading:

Jake Harper, NPR, A Drugmaker Tries to Cash In On The Opioid Epidemic, One State Law At a Time, http://www.npr.org/sections/health-shots/2017/06/12/523774660/a-drugmaker-tries-to-cash-in-on-the-opioid-epidemic-one-state-law-at-a-time